▶ Introducing MEDICAL IP’s digital twin technology that combines MEDIP PRO and NVIDIA Omniverse

▶ 10 representatives from healthcare AI sector were invited

▶ MEDICAL IP to participate as a first member in Asia… solidifying MEDICAL IP’s presence in global healthcare market

MEDICAL IP Co., Ltd. (CEO Sang Joon Park), a digital twin-based medical AI solution company, announced that it attended the Medical Imaging Council and Healthcare AI Council held at NVIDIA’s Santa Clara headquarter upon the official invitation of NVIDIA.

NVIDIA invited 10 representatives from global healthcare sector during GTC 2023, the world’s most renowned AI & metaverse conference, and Sang Joon Park (CEO, MEDICAL IP) was invited as the only member of the council from Asia.

Starting with the opening remarks of Kimberly Powell, Vice President of the NVIDIA’s Healthcare sector, global leaders in the healthcare industry discussed the latest trends in technology and direction of the technological innovation to brainstorm ways to collaborate within the medical AI industry.

During the council, Sang Joon Park, CEO of MEDICAL IP, introduced the company’s medical image-based real time digital twin technology developed by combining MEDIP PRO and NVIDIA Omniverse. Development plan and vision for expanding the solution into the metaverse through Omniverse were also shared.

*Omniverse : NVIDIA’s metaverse application production and operation platform for real-time collaboration

As a Premiere Member of NVIDIA Inception, MEDICAL IP has been discussing technological collaboration of the two companies. As part of such effort, functions for creating and editing medical image-based digital twin without time and space constraints were developed and this collaborative efforts are expected to further strengthen the partnership between the two companies.

“MEDICAL IP's participation in this event where only selected 10 people from around the world were invited, is a recognition in itself of the company’s position in the global medical market,” said Sang Joon Park, CEO of MEDICAL IP. He continued, “As the final round of tests for combined version of NVIDIA's next-generation platform Omniverse and MEDIP PRO is in progress, its progress was shared with global leaders at this council and the company's digital twin technology and products will gain visibility and overseas scalability.”